Gorjan Hrustanovic

Gorjan Hrustanovic is a Managing Director at Biotechnology Value Fund (BVF Partners L.P.) since December 2015 and holds multiple board positions, including at Kymera Therapeutics, Nimbus Therapeutics, Olema Oncology, Rain Therapeutics, and Plexium. Hrustanovic earned a Ph.D. in Biomedical Sciences with a focus on Cancer Biology and Cell Signaling from the University of California, San Francisco, where the individual was also an HHMI/GEMS Clinical Translational Science Institute Fellow. Prior academic qualifications include a B.S. in Molecular Biology and Management Science from UC San Diego.